Weight Management
5-Amino-1MQ
10-vial kit · lyophilized
From$481
ViewTirzepatide
Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor co-agonist, representing a next-generation incretin-based research target. The single…
Kit size — 10 vials per kit
$386per kit · lyophilized
Qty
1
$386Purity99.0%
HPLC verified · MS confirmedFormulaC₂₂₅H₃₄₈N₄₈O₆₈
Mol. Weight4813.5 g/mol
Half-Life~5 days
FormLyophilized powder
CAS2023788-19-2
CoA Included3rd-party testedFor Research Use Only
Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor co-agonist, representing a next-generation incretin-based research target. The single 39-amino acid molecule activates both receptor pathways, producing additive to synergistic effects on glycemic control and weight reduction compared to GLP-1 mono-agonism. Research has explored its superior efficacy in energy expenditure, adipose tissue reduction, and insulin secretion models.
Research Highlights
- Dual GIP/GLP-1 co-agonism produces superior weight reduction vs GLP-1 alone
- Significant reduction in HbA1c, fasting plasma glucose, and post-prandial insulin
- Activates hypothalamic satiety centers via dual receptor mechanism
- Superior adipose tissue reduction: subcutaneous and visceral compartments
Key References
1
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
Handpicked for you
Browse full catalogYou might also like
Selected based on your current compound and popular research combinations.